FRED HUTCHINSON CANCER CENTER
🇺🇸United States
Red and Processed Meat Effects on the Metabolome and Microbiome
- First Posted Date
- 2022-03-11
- Last Posted Date
- 2024-01-16
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 22
- Registration Number
- NCT05274906
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 250
- Registration Number
- NCT05250037
- Locations
- 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
🇺🇸Stanford Cancer Institute, Palo Alto, California, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma
Phase 1
Withdrawn
- Conditions
- Recurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRefractory Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaRecurrent Primary Mediastinal (Thymic) Large B-Cell LymphomaRecurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRefractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRefractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Interventions
- First Posted Date
- 2022-02-08
- Last Posted Date
- 2023-01-13
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT05228249
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study
- First Posted Date
- 2021-11-26
- Last Posted Date
- 2023-06-09
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT05135650
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma or Hormone Receptor Positive Her2 Negative Metastatic Refractory Breast Cancer
Phase 1
Recruiting
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous MelanomaMetastatic Acral Lentiginous MelanomaMetastatic Conjunctival MelanomaMetastatic Cutaneous MelanomaMetastatic HER2-Negative Breast CarcinomaMetastatic Mucosal MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8Pathologic Stage IIID Cutaneous Melanoma AJCC v8
- Interventions
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT05098210
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Testing Counseling and Mobile Health Interventions to Improve Physical Activity and Diet Quality in Survivors of Childhood Cancer
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2021-10-13
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 403
- Registration Number
- NCT05075759
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease
- First Posted Date
- 2021-10-05
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 72
- Registration Number
- NCT05067595
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
Phase 2
Recruiting
- Conditions
- Interventions
- Drug: FludarabineDrug: ClofarabineProcedure: Hematopoietic Cell TransplantationRadiation: Total-Body IrradiationDrug: TreosulfanProcedure: EchocardiographyProcedure: Multigated Acquisition ScanProcedure: Lumbar PunctureProcedure: Bone Marrow AspirationProcedure: Bone Marrow BiopsyProcedure: Biospecimen Collection
- First Posted Date
- 2021-08-06
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 80
- Registration Number
- NCT04994808
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Peer PrEP Referral + HIV Self-test Delivery for PrEP Initiation in Kenya
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-07-29
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 504
- Registration Number
- NCT04982250
- Locations
- 🇰🇪
Partners in Health and Research Development, Thika, Kenya
Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
Phase 2
Recruiting
- Conditions
- Diamond-Blackfan AnemiaHereditary Sideroblastic AnemiaParoxysmal Nocturnal HemoglobinuriaShwachman-Diamond SyndromeHematologic Neoplasm With Germline GATA2 MutationHematologic Neoplasm With Germline SAMD9 MutationHematologic Neoplasm With Germline SAMD9L MutationBone Marrow Failure SyndromeCongenital Amegakaryocytic Thrombocytopenia
- Interventions
- Drug: TreosulfanDrug: Fludarabine PhosphateDrug: TacrolimusDrug: MethotrexateBiological: Lapine T-Lymphocyte Immune GlobulinProcedure: Peripheral Blood Stem Cell TransplantationProcedure: Allogeneic Bone Marrow TransplantationOther: Quality-of-Life AssessmentProcedure: EchocardiographyProcedure: Multigated Acquisition ScanProcedure: Bone Marrow BiopsyProcedure: Bone Marrow AspirationProcedure: Biospecimen CollectionProcedure: X-Ray ImagingProcedure: Computed Tomography
- First Posted Date
- 2021-07-16
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT04965597
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Cohen Children's Hospital of NY, Queens, New York, United States
© Copyright 2024. All Rights Reserved by MedPath